What Is the Dose of Semaglutide for Weight Loss?

Semaglutide has emerged as a transformative option for individuals seeking sustainable weight reduction. Understanding how dosing works—from initial injections through maintenance therapy—helps you make informed decisions about whether this treatment aligns with your health goals. PlexusDx provides compounded semaglutide with personalized dosing protocols designed to maximize safety and effectiveness.

What Is Semaglutide and How Does It Function

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed to manage type 2 diabetes. The medication activates GLP-1 receptors in the brain and digestive system, creating signals that reduce hunger, increase feelings of fullness, and slow stomach emptying. This triple mechanism explains why individuals experience reduced appetite and improved portion control during treatment.

Clinical evidence from the STEP trials demonstrated that semaglutide produces meaningful weight loss across diverse populations. Participants receiving semaglutide lost approximately 15-18% of baseline body weight over 68 weeks, compared to 2-3% in the placebo group. The medication works synergistically with lifestyle modifications, making it particularly effective when combined with dietary changes and physical activity.

PlexusDx sources compounded semaglutide exclusively from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and sterility. This compounded approach allows for dosing flexibility that accommodates individual metabolic profiles and health circumstances, distinguishing it from one-size-fits-all pharmaceutical options.

Standard Semaglutide Dosing Schedule for Weight Management

Semaglutide dosing follows a carefully structured titration protocol designed to minimize side effects while gradually reaching therapeutic concentrations. Treatment typically begins at 0.25 mg administered as a subcutaneous injection once weekly. This introductory dose allows your body to acclimate to the medication while establishing injection technique and baseline tolerance.

The standard 16-week escalation pathway progresses as follows: weeks 1-4 at 0.25 mg, weeks 5-8 at 0.5 mg, weeks 9-12 at 1.0 mg, and weeks 13-16 at 1.5 mg weekly. After week 16, most individuals transition to a maintenance dose of 2.4 mg injected once per week. This gradual increase minimizes gastrointestinal discomfort and allows your metabolism to adapt systematically.

Some patients achieve adequate weight loss results at lower maintenance doses, such as 1.7 mg or 2.0 mg weekly. Treatment duration typically spans 12-24 months, though this timeline varies based on individual goals and response rates. Regular monitoring and communication with your healthcare provider ensures your dosing remains optimized throughout your treatment journey.

Personalized Dosing Approaches Using Genetic Insights

Individual variations in medication response stem partly from genetic differences in peptide pathways and GLP-1 receptor function. PlexusDx offers the Precision Peptide Genetic Test, which reveals predispositions in peptide genetic pathways affecting how your body processes and responds to semaglutide. Key genetic variants including GLP1R rs6923761 and FTO rs9939609 influence appetite regulation and weight loss capacity.

Understanding your genetic predispositions enables PlexusDx providers to recommend starting doses, titration speeds, and maintenance levels tailored to your individual biochemistry. Patients with certain genetic profiles may benefit from accelerated titration schedules, while others achieve optimal results with slower dose escalation and lower maintenance targets. This precision approach reduces trial-and-error dosing and increases the likelihood of sustained weight loss.

The Precision Peptide Genetic Test maps 14 biological pathways and provides insights into 150+ genetic factors relevant to GLP-1 therapy response. Adding this test to your treatment plan costs $99, or you can select the standalone version for $298. This genetic foundation transforms semaglutide dosing from a standardized protocol into a truly personalized therapeutic strategy.

Injectable Semaglutide Administration and Dose Adjustments

PlexusDx compounded semaglutide injections arrive pre-filled or in vial form depending on your prescription. Administration involves a simple subcutaneous injection—typically in the abdomen, thigh, or upper arm—performed once weekly on the same day each week. Most patients report that injection technique becomes automatic within the first few doses, and discomfort remains minimal with proper needle gauge and injection angle.

Your healthcare provider at PlexusDx may recommend dose adjustments based on weight loss progress, side effect tolerance, or changes in your health status. If you experience significant nausea or gastrointestinal symptoms, pausing at your current dose for an additional week or two before titrating upward can improve tolerability. Conversely, if you reach your weight loss goal before completing the standard 16-week titration, your provider may stabilize you at a lower maintenance dose.

Missing a single weekly injection has minimal impact on ongoing treatment; simply resume your regular schedule the following week. If you miss more than one dose, contact PlexusDx immediately for guidance on resuming therapy safely. Proper storage in a refrigerator between 36-46°F (2-8°C) and careful tracking of injection dates ensures consistent medication potency and therapeutic effectiveness.

Oral Semaglutide as an Alternative Dosing Option

PlexusDx also offers oral semaglutide tablets starting at $209 monthly, providing an injection-free alternative for patients who prefer tablet administration. Oral semaglutide requires specific dosing protocols: tablets are taken once daily on an empty stomach, at least 30 minutes before food, beverages, or medications. This delivery method produces comparable weight loss to injectable forms, though absorption characteristics differ slightly.

Oral semaglutide dosing typically begins at 3 mg daily, escalating to 7 mg, then 14 mg daily over 4-8 weeks depending on tolerability. The standard maintenance dose reaches 14 mg daily, though some patients achieve adequate results at 7 mg. Oral formulations allow for more granular dose adjustments and may suit individuals with needle anxiety or those preferring daily medication routines.

Both injectable and oral semaglutide from PlexusDx are compounded from licensed 503A pharmacies, HSA/FSA eligible, and available nationwide without insurance requirements. Your provider helps determine which delivery method—injection or tablet—best aligns with your lifestyle, absorption patterns, and weight loss objectives.

Frequently Asked Questions About What Is the Dose of Semaglutide for Weight Loss?

Last reviewed: May 14, 2026

Last updated: May 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.